Ultrasound Markers of Systemic Inflammation
Ultrasound in the Intensive Care Unit and Measurable Indicators of Systemic Inflammation
1 other identifier
observational
61
1 country
1
Brief Summary
The aim of this study was to measure whether the flow rate through the brachial artery and inflammatory markers were associated with the development of tissue edema in the surgical intensive care unit patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2021
CompletedFirst Submitted
Initial submission to the registry
June 2, 2022
CompletedFirst Posted
Study publicly available on registry
April 4, 2023
CompletedApril 4, 2023
May 1, 2021
1.1 years
June 2, 2022
March 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Diameter of brachial artery - 1
Measurement of a brachial artery diameter \[cm\] at admission. Admission day is considered as day 1.
within 4 hours of admission.
Diameter of brachial artery - 2
measurement of a brachial artery diameter \[cm\] on day 2 after admission.
day 2 after admission is between 24 and 48 hours after admission.
Brachial artery flow velocity - 1
measurement of a brachial artery flow velocity \[cm/s\] at admission.
within 4 hours of admission to ICU.
Brachial artery flow velocity - 2
measurement of a brachial artery flow velocity \[cm/s\] on day 2 after admission. Day 2 is Measurement of a brachial artery flow velocity \[cm/s\] between 24 and 48 h after ICU admission.
day 2 after admission is between 24 and 48 hours after admission.
Distance from skin to third metacarpal bone -1
measurement of a distance from the skin to third metacarpal bone (cm) at admission.
within 4 hours of admission.
Distance from skin to third metacarpal bone - 2
measurement of a distance from the skin to third metacarpal bone (cm) on day 2 after admission.
day 2 after admission is between 24 and 48 hours after admission.
White blood cell count - 1
blood sample analysis for white blood cell count (WBC \[10\^9/L\]) at admission.
within 4 hours of admission.
White blood cell count - 2
blood sample analysis for white blood cell count (WBC \[10\^9/L\]) on day 2 after admission.
day 2 after admission is between 24 and 48 hours after admission.
C-reactive protein - 1
blood sample analysis for C-reactive protein (CRP \[mg/L\]) concentration at admission.
within 4 hours of admission.
C-reactive protein - 2
Blood sample analysis for C-reactive protein (CRP \[mg/L\]) concentration on day 2 after admission.
day 2 after admission is between 24 and 48 hours after admission.
Procalcitonin - 1
blood sample analysis for Procalcitonin concentration (PCT \[ug/L\]) at admission.
within 4 hours of admission.
Procalcitonin - 2
Blood sample analysis for Procalcitonin concentration (PCT \[ug/L\]) on day 2 after admission.
Day 2 after admission is between 24 and 48 hours after admission.
Study Arms (1)
ICU patients
Adult patients admitted to the ICU.
Interventions
Study was conducted with Mindray T7 ultrasound machine using linear probe. Vascular ultrasound mode was used with settings depth of 50 mm and gain of 40 dB during the entire study period. The diameter and flow velocity of the brachial artery and wrist edema of the fist were measured within 24 hours of admission and the following day.
Eligibility Criteria
The patients in Osijek University Hospital who are admitted in the ICU will be included in the study.
You may qualify if:
- Adults over 18 years of age
- Postoperative surgical patients
- Signed informed consent
You may not qualify if:
- Refusal to give informed consent
- A previous thromboembolic event of the brachial artery
- Acute infection of the upper extremity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Slavica Kvolik
Osijek, 31000, Croatia
Related Publications (8)
Chakraborty RK, Burns B. Systemic Inflammatory Response Syndrome. [Updated 2021 Jul 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547669/
BACKGROUNDČavka A, Tadžić R, Grizelj I, Unfirer S, Mihaljević Z, Mihalj M et al. Endotelna funkcija - funkcionalni pokazatelj kardiovaskularnih rizičnih čimbenika. Medicinski vjesnik [Internet]. 2012 [Accessed 23.05.2021.];44((1-4)):135-146. Available from: https://hrcak.srce.hr/187756
BACKGROUNDLu D, Kassab GS. Role of shear stress and stretch in vascular mechanobiology. J R Soc Interface. 2011 Oct 7;8(63):1379-85. doi: 10.1098/rsif.2011.0177. Epub 2011 Jul 6.
PMID: 21733876BACKGROUNDChen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2017 Dec 14;9(6):7204-7218. doi: 10.18632/oncotarget.23208. eCollection 2018 Jan 23.
PMID: 29467962BACKGROUNDMortaz E, Alipoor SD, Adcock IM, Mumby S, Koenderman L. Update on Neutrophil Function in Severe Inflammation. Front Immunol. 2018 Oct 2;9:2171. doi: 10.3389/fimmu.2018.02171. eCollection 2018.
PMID: 30356867BACKGROUNDSproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018 Apr 13;9:754. doi: 10.3389/fimmu.2018.00754. eCollection 2018.
PMID: 29706967BACKGROUNDEvans DH. Colour flow and motion imaging. Proc Inst Mech Eng H. 2010;224(2):241-53. doi: 10.1243/09544119JEIM599.
PMID: 20349817BACKGROUNDKubler A, Maciejewski D, Adamik B, Kaczorowska M. Mechanical ventilation in ICUs in Poland: a multi-center point-prevalence study. Med Sci Monit. 2013 Jun 3;19:424-9. doi: 10.12659/MSM.883930.
PMID: 23727991BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Slavica Kvolik, M.D., PhD,
Osijek University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2022
First Posted
April 4, 2023
Study Start
December 1, 2020
Primary Completion
December 30, 2021
Study Completion
December 30, 2021
Last Updated
April 4, 2023
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share